Chalk Talk: Octagon TherapeuticsMarch 31, 2021
Time: 3 PM - 3:45 PM
It's time again to hear from one of our resident companies and learn what's going on inside their lab! Octagon is focused on developing targeted medicines for autoimmunity. This new class of immunomodulators is activated by disease-related biology, ideal for episodic chronic disorders. A lead program inhibits autoreactive B-cells that drive pemphigus, RA, and other autoimmune diseases.
This will be hosted via Zoom, and registration is required. Register now to get insight into Octagon's technology and ask your burning questions!